Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis

OBJECTIVE: To determine the comparative efficacy and safety of all available bone-modifying agents (BMAs) for the treatment of bone metastases in patients with advanced renal cell carcinoma (RCC). RESULTS: Three studies (259 patients) were identified for the systematic review. Two studies that compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Omae, Kenji, Tsujimoto, Yasushi, Honda, Michitaka, Kondo, Tsunenori, Tanabe, Kazunari, Fukuhara, Shunichi, Furukawa, Toshi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620305/
https://www.ncbi.nlm.nih.gov/pubmed/28978165
http://dx.doi.org/10.18632/oncotarget.20323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620305/
https://www.ncbi.nlm.nih.gov/pubmed/28978165
http://dx.doi.org/10.18632/oncotarget.20323

Ejemplares similares